Your browser doesn't support javascript.
loading
Plerixafor effectively mobilizes CD56bright NK cells in blood, providing an allograft predicted to protect against GVHD.
Wong, Peggy P C; Kariminia, Amina; Jones, David; Eaves, Connie J; Foley, Ronan; Ivison, Sabine; Couban, Stephen; Schultz, Kirk R.
Afiliación
  • Wong PPC; Division of Pediatric Hematology/Oncology/Blood and Marrow Transplant, BC Children's Hospital, Vancouver, BC, Canada.
  • Kariminia A; Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
  • Jones D; Michael Cuccione Childhood Cancer Research Program, BC Children's Hospital Research Institute, Vancouver, BC, Canada.
  • Eaves CJ; Department of Medicine, Memorial University, St. Johns, NL, Canada.
  • Foley R; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Ivison S; Department of Medicine and.
  • Couban S; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
  • Schultz KR; Hamilton Health Sciences Centre, Hamilton, ON, Canada.
Blood ; 131(25): 2863-2866, 2018 06 21.
Article en En | MEDLINE | ID: mdl-29728400

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Células Asesinas Naturales / Antígeno CD56 / Enfermedad Injerto contra Huésped / Compuestos Heterocíclicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Humans / Middle aged Idioma: En Revista: Blood Año: 2018 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Células Asesinas Naturales / Antígeno CD56 / Enfermedad Injerto contra Huésped / Compuestos Heterocíclicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Humans / Middle aged Idioma: En Revista: Blood Año: 2018 Tipo del documento: Article País de afiliación: Canadá